» Journals » J Thromb Haemost

Journal of Thrombosis and Haemostasis : Jth

The Journal of Thrombosis and Haemostasis (JTH) is a leading scientific journal dedicated to the study of blood clotting disorders and their management. It publishes high-quality research articles, reviews, and case reports that contribute to the understanding of thrombosis, hemostasis, and related fields. JTH serves as a valuable resource for clinicians, researchers, and healthcare professionals seeking the latest advancements in this critical area of medicine.

Details
Abbr. J Thromb Haemost
Publisher Elsevier
Start 2003
End Continuing
Frequency Monthly
p-ISSN 1538-7933
e-ISSN 1538-7836
Country United Kingdom
Language English
Specialty Hematology
Metrics
h-index / Ranks: 605 212
SJR / Ranks: 1080 2128
CiteScore / Ranks: 280 22.10
JIF / Ranks: 433 10.4
Recent Articles
1.
Thakkar K, Naseer S, Chowdhury S, Mondal S, Shrivastva S, Ribeyron L, et al.
J Thromb Haemost . 2025 Mar; PMID: 40089183
Background: Thrombopoietin receptor signalling permits the thrombocyte lineage development in human, mice as well as zebrafish. While the sequence, structure, signalling, and function of TpoR is well-conserved in humans and...
2.
Dybedal I, Iversen N, Jacobsen A, Bjorge L, Chaireti R, Henriksson C, et al.
J Thromb Haemost . 2025 Mar; PMID: 40086756
Background: The optimal anticoagulant regimen to prevent pregnancy-related venous thrombosis (VT) in women with antithrombin (AT) deficiency is unknown. Objectives: To identify optimal doses of low molecular weight heparin (LMWH)...
3.
Walker G, Borroni E, Haider R, Olgasi C, Borsotti C, Follenzi A
J Thromb Haemost . 2025 Mar; PMID: 40086755
Background: Factor VIII (FVIII), an essential coagulation co-factor and independent cancer associated thrombotic risk factor, has recently been shown to be synthesized directly by a broad profile of cancers. With...
4.
Douketis J, Li N, St John M, Nixon J, Moffat K, Shaw J, et al.
J Thromb Haemost . 2025 Mar; PMID: 40086754
Background: There is uncertainty about the perioperative management of patients who are receiving a direct oral anticoagulant (DOAC) and require an elective high-bleed-risk surgery, including those who are undergoing a...
5.
Andrew L, Garven A, Taylor T, Bates S, Duffett L, Dubois S, et al.
J Thromb Haemost . 2025 Mar; PMID: 40086753
Background: There is a need to better understand barriers to recruitment and participation in randomized controlled trials (RCTs) evaluating postpartum thromboprophylaxis, as previous trials had low recruitment and were not...
6.
Goh T, Ju L, Waterhouse A
J Thromb Haemost . 2025 Mar; PMID: 40058704
Cardiovascular mechanical circulatory support (MCS) device use triggers thrombosis and haemostatic disorders, which may become fatal if thrombi occlude circulation or cause embolic complications. Consequently, anti-thrombotic medications are administered, which...
7.
Chauhan W, Sj S, Ferdowsi S, Sohel A, Zennadi R
J Thromb Haemost . 2025 Mar; PMID: 40058703
Background: Oxidative stress is one of the aging hallmarks. Small non-coding nucleolar RNAs (snoRNAs) of the ribosomal protein L13a (Rpl13a) locus are master regulators of reactive oxygen species (ROS) and...
8.
Joly B, Deniau H, Doinel C, Brouillard A, Siguret V, Coppo P, et al.
J Thromb Haemost . 2025 Mar; PMID: 40058702
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy characterized by a severe functional deficiency of ADAMTS13. Measuring ADAMTS13 activity is crucial for diagnosing TTP (<10 IU/dL), monitoring treatments, and...
9.
10.